gilotrif - afatinib tablet, film coated
(Afatinib)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: Gilotrif treats metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations as first-line therapy, and metastatic squamous NSCLC that has progressed after platinum-based chemotherapy.